comparemela.com

Latest Breaking News On - Genexosome technologies inc - Page 1 : comparemela.com

Worldwide Next-Generation Sequencing Industry to 2025 - Key Drivers and Trends

Worldwide Next-Generation Sequencing Industry to 2025 - Key Drivers and Trends
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Hospital Researcher Sentenced to Prison for Conspiring to Steal Trade Secrets and Sell to China

Hospital Researcher Sentenced to Prison for Conspiring to Steal Trade Secrets and Sell to China Details Written by Imperial Valley News Washington, DC - An Ohio man was sentenced Monday to 33 months in prison for conspiring to steal exosome-related trade secrets concerning the research, identification and treatment of a range of pediatric medical conditions. Yu Zhou, 51, of Dublin, Ohio, pleaded guilty in December 2020 to stealing scientific trade secrets related to exosomes and exosome isolation from Nationwide Children’s Hospital’s Research Institute for his own personal financial gain. Zhou also conspired to commit wire fraud. “Yu Zhou sought to exploit U.S. taxpayer dollars intended to fund critical, life-saving research at Nationwide Children’s Hospital through the whole-sale theft of their trade secrets,” said Assistant Attorney General John C. Demers for the Justice Department’s National Security Division. “Zhou’s greed was enco

Second Medical Researcher Sentenced in Hospital IP Theft Case

Get Permission A second former medical researcher has been sentenced to serve time in federal prison for his part in a conspiracy to steal trade secrets from an Ohio children’s hospital and sell them to China. Yu Zhou, a former medical researcher at Nationwide Children’s Hospital’s Research Institute in Columbus, Ohio, was sentenced to serve 33 months in federal prison for conspiring to steal the institute s exosome-related trade secrets concerning the research, identification and treatment of a range of pediatric medical conditions, according to the Department of Justice. Zhou, who also was charged with conspiracy to commit wire fraud, pleaded guilty to all the charges in December, prosecutors say.

Chinese National Gets 33 Months For Lab Trade Secret Theft

ADVERTISEMENT ADVERTISEMENT Chinese National Gets 33 Months For Lab Trade Secret Theft Law360 (April 19, 2021, 9:30 PM EDT) A Chinese national was sentenced in Ohio federal court Monday to 33 months in prison for conspiring to steal trade secrets from a children s hospital where he worked as a researcher along with his wife, who was previously sentenced to 30 months. Yu Zhou and his wife, co-conspirator Li Chen, must also forfeit $1.45 million, 500,000 shares of common stock of Avalon GloboCare Corp. and 400 shares of common stock of GenExosome Technologies Inc. and pay $2.6 million in restitution, according to the U.S. Attorney s Office for the Southern District of Ohio.

Global Liquid Biopsy Market Review 2019-2020 and Forecast 2021-2025 with Profiles of Over 200 Competitors

Share this article Share this article ResearchAndMarkets.com s offering. The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted). Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populations; cancer screening and early detection; and recurrence monitoring for cancer patients. Biomarker types of most interest include cell-free DNA (cfDNA), circulating tumor cells (CTCs) and exosomes. Ongoing advances in sensitive molecular technologies such as next-generation DNA sequencing (NGS) and digital polymerase chain reaction (dPCR) enable the detection of biomarkers that are present

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.